Navigation Links
FLT3 in Medical News

S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias

SINGAPORE, Nov. 27 /PRNewswire/ -- S*BIO Pte Ltd today announced the expansion of its proprietary pipeline, with its third development candidate, SB1317. This is a novel orally-available small molecule compound targeted for the treatment of acute leukemias. SB1317 is designed to selectively ...

Low micro-RNA level linked to high gene activity in AML

...tions in two genes in the leukemic cells: NPM1 and flt3 (pronounced Flit-3). The pattern of microRNA m...l gene. Furthermore, 26 of the 85 patients had flt3 mutations. These cases also had high levels of a m...igh levels of miR-155 were closely associated with flt3 mutations, they were independent of the mutation (...

Sorafenib Slows Growth of Some Leukemias

...ve the drug to mice with leukemia cells with known flt3 mutations and to leukemia patients with and without the flt3 mutation. Sorafenib slowed growth and induced cell death in the flt3 mutant leukemia cells and increased survival of th...

Kidney cancer drug attacks a major type of acute myeloid leukemia

...ease. After in vitro tests showed that sorafenib inhibited the growth of flt3 mutant leukemia cell colonies, the research team tested the medication in a...ly results of new therapies under development that more narrowly target the flt3 gene. Andreeff says the drug's ability to hit multiple kinases probably acc...

S*BIO's Oral JAK2 Inhibitor SB1518 Demonstrates Therapeutic Potential for the Treatment of Myeloproliferative and Other Hematological Disorders

... models of hematological malignancies SB1317, a novel potent inhibitor of flt3 kinase and CDKs 1, 2 and 9, demonstrated therapeutic potential for the treatment of hematological malignancies. flt3 is the most common mutated gene in acute myeloid leukemia (AML), and CDK1...
FLT3 in Medical Technology

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

...lapsed acute myelogenous leukemia (AML) expressing flt3 activating mutations. The study was designed to s...nt inhibitor of several tyrosine kinases including flt3 and a Janus kinase (JAK2). In leukemic cells, lestaurtinib inhibits flt3 activity and induces cell death (apoptosis). In my...

Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex

... Symadex (formerly C-1311) is the lead compound from a new series of agents, the imidazoacridinones, which have been shown to be potent and selective flt3 receptor tyrosine kinase inhibitors in vitro. Symadex is currently in Phase 2 clinical trials in oncology indications. Xanthus is also exploring the u...
FLT3 in Biological News

Washington University scientists first to sequence genome of cancer patient

... toward cancer, and then one by one, the other genetic alterations were acquired, with each contributing something to the cancer. One mutation, in the flt3 gene, was not present in all of the tumor cells, and they suspect that it was the last one to occur. "The final mutation may represent a tipping point...

Dendritic cells offer new therapeutic target for drugs to treat MS and other autoimmune disease

...foreign invaders to soldiering T-cells. "Someday, using a drug to block flt3 gene signaling could stop dendritic cells from triggering harmful responses...ound called CEP-701, already known to block actions of the growth-promoting flt3 gene, on human dendritic cells and in mice engineered to mimic multiple scl...
FLT3 in Biological Technology

Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer

...istration filing of Gleevec(TM) in Ph+ adult acute lymphoblastic leukemia (ALL) and, as global clinical project leader, successfully brought the first flt3 kinase inhibitor PKC412 (Midostaurin) to Phase 3 in acute myelogenous leukemia (AML). Earlier in her career at Novartis, Dr. Cohen was responsible for...
Other Tags
(Date:4/24/2015)... 24, 2015 With years of experience ... is now proud to be partnered with a veterinary ... animals a year. This partnership has brought new payment ... , After providing an in-house payment plan for ... Hospital (VMTH) wanted to increase financing options available to ...
(Date:4/24/2015)... 2015 IntelliSoft Group, LLC, a ... contract management software, featured IntelliCred Version 14.2 during ... Annual Educational Conference (IAMSS) on April 23-24 ... Brook, Illinois. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive ... & 2 suppliers, content providers, associations and government bodies. ... value chain, see them converge in Berlin. This year’s ... from those companies currently at the forefront of Europe’s ... on customer centric products, ParkTAG are one of the ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of ... forces are used worldwide, and how they would not be ... says that the nations have been trained to build up ... to the confusion and distrust. , “The nations believe ... forced compliance, unjust rules and laws, and the rape of ...
(Date:4/24/2015)... 2015 Recent research by the CareerBuilder ... therapists and their assistants are among the top 10 ... by the year 2023. , Physical therapists are ... growth and greatest potential for expansion in the future. ... that while physical therapists can offer great relief to ...
Breaking Medicine News(10 mins):Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2Health News:Huntsville Medical Doctor Explains Why Physical Therapy May Not Treat Muscle Numbness Adequately 2
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, ... million users across iOS and Android ... begun integrating biofeedback into the platform to allow patients ... outcomes. For the first time, patients will be able ... a dose impacts important biometrics, such as glucose levels ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
Other Contents